云南阿昌族G6PD基因突变G487A在DF213中的表达

为获得阿昌族G6PDWT和G6PDG487A重组蛋白,研究G6PDG487A的结构和功能改变,从云南省德宏州梁河县杞木寨乡湾中村阿昌族聚集地的G6PD缺陷家系先证者和正常阿昌族个体全血提取RNA,经RT-巢式PCR得cDNA,将cDNA克隆至pMD18-Tsimple载体中并测序;错配碱基经定点突变修复后,目的基因亚克隆至pThioHis(A)载体,构建了阿昌族G6PD基因野生型和G487A突变型原核表达载体:pThioHis(A)-AChang-G6PDWT和pThioHis(A)-AChang-G6PDG487A。用重组质粒转化E.coli Competent Cells DF213(G6PD defeciency),经IPTG诱导G6PD表达、10%SDS-PAGE电泳检测表达蛋白和紫外340nm定量测定G6PD活性的分析表明,pThioHis(A)-AChang-G6PDWT和pThioHis(A)-AChang-G6PDG487A在DF213中成功表达,分子量约为59kDa。IPTG诱导0、3、6、9、和12h后,G6PD活性逐渐增高,G6PD基因WT表达的酶活性约是G487A的20-25倍。表达载体的构建以及G6PDcDNA在DF213中成功表达,为重组酶G6PDG487A的进一步研究奠定了基础。     

G6PD通过细胞周期蛋白D1/D2调控人黑色素瘤细胞周期的进程

葡萄糖-6-磷酸脱氢酶(G6PD)在人皮肤黑色素瘤A375细胞中处于高表达与高活性状态, 但G6PD在黑色素瘤发生发展过程中的作用及其具体机制尚不明确.本文在前期运用 siRNA方法构建G6PD敲减的黑色素瘤A375稳转细胞(A375-G6PDΔ)基础上,构建表达载体pBabe-puro-G6PDWT在A375-G6PDΔ细胞中过表达野生型的G6PD基因,从而构建G6PD表达恢复的稳转细胞(A375-G6PDΔ-G6PDWT).3株细胞A375-WT、A375-G6PDΔ和 A375-G6PDΔ-G6PDWT经G6PD酶活性测定、MTT测定、克隆形成实验、流式细胞仪分析细胞周期和Western 印迹检测.结果显示,A375-G6PDΔ-G6PDWT细胞的G6PD蛋白表达量 (0.847 ± 0.080)及其活性(0.394 ± 0.029)分别是A375-G6PDΔ的3.28倍(P＜0.01) 和7.34倍(P＜0.01),分别是A375-WT细胞的91-57%和2.12倍(P＜0.05).与A375-WT细 胞相比,A375-G6PDΔ细胞G0/G1期细胞数增加,S期细胞数减少,增殖指数PI降低了25-70%（P＜0.05）,细胞周期蛋白D1/D2、细胞周期蛋白E表达分别下降37.4%、54.3% (P＜0.01)和17.3%;而A375-G6PDΔ-G6PDWT细胞呈现G1/S期阻滞解除,细胞周期蛋白D1/D2蛋白分别恢复到A375-WT细胞的89.5%和87.6%,细胞周期蛋白E表达未见 恢复,呈现生长增殖和克隆形成率的恢复并接近于A375-WT细胞. 结果提示,G6PD通 过细胞周期蛋白D1/D2调控人皮肤黑色素瘤A375细胞G1期向S期转换的进程,这为黑色 素瘤发病机制的研究提供了新的思路.     

PCR-RFLP和PCR-SSCP方法对弱精子症精子mtATPase6基因突变的检测

为了检测弱精子症精子mtATPase6基因突变,采用PCR方法扩增了17例弱精子症mtDNA8602～9416区域815bp目的片段,用MspI和HaeⅢ限制性内切酶酶切,分别用琼脂糖凝胶电泳、聚丙烯酰胺凝胶电泳和单链构像多态性(SSCP)筛查突变。筛选出3例突变标本,经测序确认突变位点和突变性质。结果显示17例标本全部扩增出mtDNA8602～9416的815bp目的片段,PCR产物经MspI限制性内切酶酶切后电泳结果与剑桥序列预期酶切图谱相一致。PCR产物经HaeⅢ酶切,聚丙烯酰胺凝胶电泳图谱上出现泳动带的异常,在17例弱精子症中共筛选出2例酶切片段异常标本。PCR-HaeⅢ酶切产物的SSCP电泳图谱分析结果显示,在PCR-RFLP(HaeⅢ)电泳图谱正常的15例弱精子症标本中筛选出1例异常。两种方法在弱精子症精子标本中筛选出mtATPase6基因突变3例(3/17,17.7%)。3例测序结果发现A8701G、C8943T、C8964T、T8966C、G9053A、C9060A、C9075T、A9120G、C9296T共9个点突变,其中A8701G、T8966C、G9053A三个突变为错义突变,其余均为同义突变。上述结果提示,弱精子症精子mtATPase6基因存在较高突变率;PCR-RFLP和PCR-SSCP能简单、快速、灵敏地筛选mtATPase6基因突变。     

λ DNA酶切片段与pUC19克隆载体的构建与鉴定

目的:构建λDNA片段/p UC19重组质粒并鉴定。方法:将克隆质粒p UC19和λDNA进行Hind III酶切、碱法提取质粒,琼脂糖凝胶电泳纯化鉴定、紫外分光光度测定,T4DNA连接酶切产物、冰Ca Cl2转化E.coli DH5α菌株使之成为感受态细胞、蓝白斑筛选法筛选并鉴定重组转化子。结果:1所提质粒p UC19电泳获得预期的3条带,经由标准DNA Markar比对准确,提取浓度满足酶切需要。2酶切质粒p UC19电泳获得预期的1条带,λDNA片段电泳获得的4条带,经由标准DNA Markar比对准确。3培养皿不同区域出现数量不等的蓝色、白色菌斑。结论:应用质粒p UC19可成功构建λDNA片段/p UC19重组质粒。经鉴定,该克隆载体能够导入菌株E.coli DH5α,转化效率较高。     

人ABCB6表达载体的构建及稳定表达细胞株A375的筛选

目的构建表达载体pIRES2-ZsGreen1-ABCB6,在转染的人黑素瘤细胞系株A375中筛选其稳定表达的细胞株。方法抽取健康人外周血,分离外周血单个核细胞,提取总RNA,逆转录获取cDNA序列,加入特异性引物经PCR扩增获得ABCB6cDNA双链,再经过BglII、EcoRI双酶切PCR产物及质粒载体pIRES2-ZsGreen1,酶切产物经回收、T4DNA连接酶连接,产物转化到大肠杆菌DH5α,挑取阳性克隆经菌落PCR鉴定、酶切鉴定和测序分析,以确定构建质粒正确。转染人黑素瘤细胞株A375,G418筛选稳定表达ABCB6的单克隆细胞株,应用荧光显微镜鉴定ABCB6蛋白的表达情况。结果 pIRES2-ZsGreen1-ABCB6质粒经菌落PCR、酶切、测序鉴定正确,经过G418筛选后获得稳定细胞株,在荧光显微镜下可观察到绿色荧光蛋白在A375细胞中的表达。结论表达载体pIRES2-ZsGreen1-ABCB6构建正确,并成功筛选出稳定表达ABCB6的A375细胞株,为进一步研究ABCB6的生物学功能奠定了良好基础。     

杨树葡萄糖-6-磷酸脱氢酶(G6PDH)基因启动子的克隆与分析

葡萄糖-6-磷酸脱氢酶是磷酸戊糖途径的关键性调控限速酶,其主要功能是为脂肪酸合成、氮还原和谷胱甘肽等生物分子合成提供还原力NADPH,也为核酸合成提供戊糖;此外,还参加非生物逆境胁迫应答反应.因此,G6PDH对植物的生长发育起着非常重要的作用.本文利用甜杨G6PDH基因和毛果杨基因组序列,通过PCR获得了甜杨G6PDH基因上游1 400bp的序列.序列分析结果表明,该序列具有启动子的基本元件TATA-bOX、CAAT-box.此外,还包含多个胁迫诱导元件,如低温诱导元件LTR,盐诱导元件GT-1,抗冻、缺水、脱落酸、抗寒元件MYB和MYC,以及光响应元件L-box、G-box、3AF-1、TC丰富区等.     

含G0S2基因启动子的荧光素酶报告基因载体的构建

目的:克隆人G0S2基因启动子并构建荧光素酶报告基因载体,为进一步研究G0S2基因转录调控提供质粒。方法:利用PCR技术从人胚肾293A细胞基因组DNA中克隆获得G0S2基因启动子的DNA片段,将其克隆至pGL3-basic表达载体中,并转化人大肠杆菌DH5α,经限制性内切酶酶切、PCR及测序鉴定得到确认;将重组载体质粒与半乳糖苷酶表达质粒psV-β-Galactosidase共转染至大鼠血管平滑肌细胞(VSMC),检测细胞中荧光素酶的活性。结果:pGL3-G0S2-Promoter重组质粒插入片段和相邻序列正确,克隆的G0S2基因片段有启动子活性(P0.05)。结论:成功构建了pGL3-G0S2-Promoter报告基因质粒,为进一步研究G0S2基因的表达奠定了基础。     

龟裂链霉菌zwf2基因阻断提高土霉素生物合成

葡萄糖-6-磷酸脱氢酶(G6PDH)是链霉菌磷酸戊糖途径中第一个酶("看家"酶),也是形成NADPH的关键酶,由zwf1和zwf2基因编码.以温敏型质粒pKC1139为基础构建了用于阻断龟裂链霉菌zwf2的重组质粒pKC1139-zwf2',通过大肠杆菌GM2929去甲基化pKC1139-zwf2'后电转至原始龟裂链霉菌M4018感受态细胞,筛选得到转化子.转化子进一步通过PCR鉴定和点杂交印迹分析鉴定,证明是zwf2基因阻断的阳性突变子命名为M4018-△zwf2.以原始菌株为对照,突变子摇瓶发酵结果表明:突变子的葡萄糖-6-磷酸脱氢酶酶活是原始菌的50%左右,但土霉素生物合成水平则提高了27%;在细胞生长方面,二者均在第4d进入生长稳定期而开始大量合成土霉素,发酵结束时细胞菌体浓度基本相同,但突变子的单位菌丝体土霉素生物合成能力则提高了31%.因此,zwf2的阻断有利于土霉素的生物合成,而对细胞生长没有明显影响.     

一种简便的DNA定量分子量标准的制备

目的：制备一种具有琼脂糖凝胶电泳定量功能的DNA分子量标准。方法：以pMD18-TSimple载体为基础骨架构建了长度为4.7kb的质粒,应用定点突变的方法,在载体上分别间隔100bp、200bp、400bp、800bp、1200bp处,加入了HindⅢ限制性内切酶的酶切位点,将该质粒扩增后并应用HindⅢ酶切后,1.5%琼脂糖凝胶电泳鉴定。结果：获得的分子量条带大小依次为100bp、200bp、400bp、800bp、1200bp和2000bp,每次使用4μl可获得质量范围为10ng、20ng、40ng、80ng、120ng和200ng的定量标准品。结论：应用该方法制备标准品,具有制备简单、成本低、定量快速等优点。     

云南傣族中所见的G6PD突变型

利用错配碱基PCR/酶切法,在云南傣族中发现ntl388 G→A、ntl376 G→T和nt392 G→T G6PD基因突变型。其中主要为1388突变(18/23)。此3种突变也见于华南地区的汉族中,而有别于非中国人的突变型。提示傣族与汉族可能有同一民族渊源。利用PCR-SSCP方法在不同外显子中发现3例未知突变,待进一步DNA序列测定定型。 Abstract:By using mis-matched PCR followed by endonuclease digestion,G6PD gene mutations nt1388G→A,nt1376G→T,and nt392G→T were found among Dai national minority in Yunnan Province.Among these mutations,18 out 23 were nt1388G→A mutation.These three types of mutation were also found in Han people in the southern China,and never reported in other ethnic groups worldwide.It implied that the Han and Dai people perhaps had the same ethnic origin.Mutations of three undefined cases were identified in different exons by PCR-SSCP method.The exact mutation point will be detected by DNA sequencing under further investigation.     

Russian Article pp. 279-284

The accumulation of nucleic and protein (amino nitrogen) components as decomposition products of the process of autolysis of Saccharomyces cerevisiae yeast cells was studied at 50°C under the effect of various membranotropic additives. The influence of the added n-alcohols, n-fatty acids and several peptides was investigated in the range of concentration of 0.1–0.5 M. The maximal acceleration of the autolysis has been demonstrated under the effect of additives with a hydrophobicity of 7.5–8.5 ccal/M. In all the investigated concentrations stearic acid and octadecyl alcohol have an inhibitory influence. The role of the hydrophobic influences and the mechanism of autolysis are discussed.     

A galactokinase of Mycobacterium sp. 279 galactose mutant

A galactokinase and the other enzymes of a galactose catabolic pathway were found in Mycobacterium sp. 279 galactose mutant. The galactokinase was partially purified in a procedure involving ammonium sulfate precipitation, Sephadex G-100 filtration and DEAE-cellulose chromatography. The enzyme was 170-fold purified with 25% of recovery. It was most active at pH 7.8-8.0 in the presence of Mg2+, CO2+, Mn2+ or Fe2+ ions. The molecular weight of the enzyme as determined by Sephadex G-100 filtration amounted to 41,700. The apparent Michaelis constants for galactose and ATP in spectrophotometric test were 1.0 mM and 0.29 mM, respectively. Mercuric compounds at concentration of 0.4 mM completely blocked the enzyme. The galactokinase was quite stable during storage at moderatory temperatures and neutral pH but underwent rapid inactivation on heating above 50 degrees C.     

Importance of glutamate 279 for the coenzyme binding of human glutamate dehydrogenase

Although the structure of glutamate dehydrogenase (GDH) has been reported from various sources including mammalian GDH, there are conflicting views regarding the location and mechanism of actions of the coenzyme binding. We have expanded these speculations by photoaffinity labeling and cassette mutagenesis. Photoaffinity labeling with a specific probe, [(32)P]nicotinamide 2-azidoadenosine dinucleotide, was used to identify the NAD(+) binding site within human GDH encoded by the synthetic human GDH gene and expressed in Escherichia coli as a soluble protein. Photolabel-containing peptides generated with trypsin were isolated by immobilized boronate affinity chromatography. Photolabeling of these peptides was most effectively prevented by the presence of NAD(+) during photolysis, demonstrating a selectivity of the photoprobe for the NAD(+) binding site. Amino acid sequencing and compositional analysis identified Glu(279) as the site of photoinsertion into human GDH, suggesting that Glu(279) is located at or near the NAD(+) binding site. The importance of the Glu(279) residue in the binding of NAD(+) was further examined by cassette mutagenesis with mutant enzymes containing Arg, Gly, Leu, Met, or Tyr at position 279. The mutagenesis at Glu(279) has no effects on the expression or stability of the different mutants. The K(m) values for NAD(+) were 10-14-fold greater for the mutant GDHs than for wild-type GDH, whereas the V(max) values were similar for wild-type and mutant GDHs. The efficiency (k(cat)/K(m)) of the mutant GDH was reduced up to 18-fold. The decreased efficiency of the mutants results from the increase in K(m) values for NAD(+). In contrast to the K(m) values for NAD(+), wild-type and mutant GDHs show similar K(m) values for glutamate, indicating that substitution at position 279 had no appreciable effect on the affinity of enzyme for glutamate. There were no differences in sensitivities to ADP activation and GTP inhibition between wild-type and mutant GDH, suggesting that Glu(279) is not directly involved in allosteric regulation. The results with photoaffinity labeling and cassette mutagenesis studies suggest that Glu(279) plays an important role for efficient binding of NAD(+) to human GDH.